Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors
Status:
RECRUITING
Trial end date:
2029-04-24
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability, dosimetry and preliminary efficacy of \[177Lu\]Lu-DFC413 and safety and imaging properties of \[68Ga\]Ga-NNS309 in patients aged 18 years with solid tumors